Edwards Lifesciences Corporation Stock London S.E.
Equities
0REN
US28176E1082
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
77.56 CHF | +5.72% | -.--% | -.--% |
03:19pm | Sector Update: Health Care Stocks Steady Premarket Monday | MT |
01:13pm | Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash | MT |
Sales 2024 * | 6.56B 5.89B 8.92B | Sales 2025 * | 7.2B 6.47B 9.8B | Capitalization | 52.36B 47.01B 71.21B |
---|---|---|---|---|---|
Net income 2024 * | 1.61B 1.45B 2.19B | Net income 2025 * | 1.86B 1.67B 2.53B | EV / Sales 2024 * | 7.72 x |
Net cash position 2024 * | 1.7B 1.53B 2.31B | Net cash position 2025 * | 2.84B 2.55B 3.86B | EV / Sales 2025 * | 6.87 x |
P/E ratio 2024 * |
32.9
x | P/E ratio 2025 * |
28.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.59% |
Latest transcript on Edwards Lifesciences Corporation
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 14-12-31 | |
Scott Ullem
DFI | Director of Finance/CFO | 57 | 13-12-31 |
Todd Brinton
CTO | Chief Tech/Sci/R&D Officer | - | 19-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leslie Heisz
BRD | Director/Board Member | 63 | 16-07-04 |
Chairman | 67 | 14-11-12 | |
Steven Loranger
BRD | Director/Board Member | 72 | 16-03-15 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.39% | 217B | |
+12.37% | 190B | |
+19.97% | 143B | |
+30.38% | 111B | |
+1.44% | 64.59B | |
-0.16% | 48.45B | |
-5.30% | 38.03B | |
+0.53% | 35.6B | |
+21.17% | 30.31B |
- Stock Market
- Equities
- EW Stock
- 0REN Stock